• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性皮肤卟啉症患者唾液中的卟啉浓度

Salivary porphyrin concentration in porphyria cutanea tarda.

作者信息

Moran M J, Santos J L, Fontanellas A, Sepulveda P, Enriquez de Salamanca R

机构信息

Porphyria Unit, Hospital Universitario Doce de Octubre, Madrid, Spain.

出版信息

J Dermatol Sci. 1993 Oct;6(2):155-8. doi: 10.1016/0923-1811(93)90006-b.

DOI:10.1016/0923-1811(93)90006-b
PMID:7903863
Abstract

To assess the clinical utility of saliva samples, serum, urine and saliva porphyrin concentration were fluorometrically measured in 31 patients with porphyria cutanea tarda. In comparison with normal values, porphyrin mean levels were 20-fold increased in serum and urine but only 3-fold in saliva. Saliva porphyrin concentration exhibited significant but weak correlations with porphyrin levels in serum (r = 0.69) and urine (r = 0.67). However, saliva porphyrins were not more closely correlated with protein-unbound serum porphyrins (r = 0.57). This finding suggests that saliva porphyrin concentration does not simply correspond to the filtered free fraction of serum porphyrins. Nevertheless, measurement of saliva porphyrins could represent a valuable non-invasive alternative to serum porphyrins in the monitoring of patients with porphyria cutanea tarda.

摘要

为评估唾液样本的临床实用性,对31例迟发性皮肤卟啉病患者的血清、尿液和唾液中的卟啉浓度进行了荧光测定。与正常值相比,血清和尿液中的卟啉平均水平升高了20倍,而唾液中仅升高了3倍。唾液卟啉浓度与血清(r = 0.69)和尿液(r = 0.67)中的卟啉水平呈显著但较弱的相关性。然而,唾液卟啉与非蛋白结合血清卟啉的相关性并不更强(r = 0.57)。这一发现表明,唾液卟啉浓度并非简单地对应于血清卟啉的滤过游离部分。尽管如此,在迟发性皮肤卟啉病患者的监测中,唾液卟啉的测定可能是血清卟啉测定的一种有价值的非侵入性替代方法。

相似文献

1
Salivary porphyrin concentration in porphyria cutanea tarda.迟发性皮肤卟啉症患者唾液中的卟啉浓度
J Dermatol Sci. 1993 Oct;6(2):155-8. doi: 10.1016/0923-1811(93)90006-b.
2
Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.迟发性皮肤卟啉症中游离和蛋白结合血浆卟啉水平与尿卟啉之间的相关性。
Int J Biochem Cell Biol. 1995 Jun;27(6):585-8. doi: 10.1016/1357-2725(95)00017-J.
3
Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces.肝胆疾病、慢性丙型肝炎和乙型肝炎病毒感染以及α-干扰素对血浆、尿液和粪便中卟啉谱的影响。
J Gastroenterol Hepatol. 2000 Feb;15(2):192-201. doi: 10.1046/j.1440-1746.2000.02065.x.
4
Porphyrin abnormalities in acquired immunodeficiency syndrome.
Arch Dermatol. 1996 Dec;132(12):1443-7.
5
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.迟发性皮肤卟啉症3周大鼠模型中的细胞色素P450诱导、尿卟啉原脱羧酶抑制、卟啉积累与排泄以及性别影响
Toxicol Appl Pharmacol. 1997 Dec;147(2):289-99. doi: 10.1006/taap.1997.8282.
6
Porphyrin metabolism abnormalities and its treatment in a uremic patient with porphyria cutanea tarda.迟发性皮肤卟啉病尿毒症患者的卟啉代谢异常及其治疗
Nephron. 1993;63(2):235-6. doi: 10.1159/000187193.
7
Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry.通过高效薄层层析法、高效液相色谱法和液体二次离子质谱法对人类迟发性皮肤卟啉症患者及用六氯苯处理的大鼠体内新的卟啉代谢产物进行分离与鉴定。
Biomed Chromatogr. 1995 May-Jun;9(3):113-22. doi: 10.1002/bmc.1130090302.
8
[Data on the elimination of porphyrin in urine in porphyria cutanea tarda].[迟发性皮肤卟啉病患者尿液中卟啉消除的数据]
Boll Soc Ital Biol Sper. 1955 Nov-Dec;31(11-12):1670-2.
9
Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.一名接受慢性非卧床腹膜透析患者的迟发性皮肤卟啉症
J Am Soc Nephrol. 1996 Mar;7(3):397-402. doi: 10.1681/ASN.V73397.
10
Dual porphyria of coexisting variegata and cutanea tarda.同时存在的混合型卟啉病(杂色卟啉病和迟发性皮肤卟啉病)。
Eur J Clin Chem Clin Biochem. 1995 Jul;33(7):405-10. doi: 10.1515/cclm.1995.33.7.405.